×
About 14,123 results

ALLMedicine™ Sudden Cardiac Death Center

Research & Reviews  4,567 results

Prevalence and determinants of peripheral arterial disease in children with nephrotic s...
https://doi.org/10.1371/journal.pone.0266432
PloS One; Akinyosoye G, Solarin AU et. al.

Aug 12th, 2022 - Peripheral arterial disease (PAD) is the least studied complication of nephrotic syndrome (NS). Risk factors which predispose children with NS to developing PAD include hyperlipidaemia, hypertension and prolonged use of steroids. The development o...

Incidence and clinical impact of tachyarrhythmic events following transcatheter aortic ...
https://doi.org/10.1016/j.hrthm.2022.07.028
Heart Rhythm; Nuche J, Panagides V et. al.

Aug 12th, 2022 - Transcatheter aortic valve replacement (TAVR) is well-established for treating severe symptomatic aortic stenosis. Whereas broad information exists about the epidemiology, clinical implications and management of bradyarrhythmias after TAVR, data a...

An autopsy case of sudden unexpected death with Barlow's disease.
https://doi.org/10.1016/j.carpath.2022.107462
Cardiovascular Pathology : the Official Journal of the So... Hata Y, Tomita N et. al.

Aug 12th, 2022 - A 45-year-old man was clinically diagnosed with mitral valve regurgitation 2 years before death. The autopsy showed left ventricular hypertrophy and mitral valve prolapse of the bileaflet with billowing valve and excessively thickened leaflet, the...

Diagnosis and Management of Pulmonary Embolism.
https://doi.org/10.1016/j.emc.2022.05.008
Emergency Medicine Clinics of North America; Trott T, Bowman J

Aug 12th, 2022 - Pulmonary embolism is a challenging pathology commonly faced by emergency physicians, and diagnosis and management remain a crucial skill set. Inherent to the challenge is the breadth of presentation, ranging from asymptomatic pulmonary emboli to ...

Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
https://clinicaltrials.gov/ct2/show/NCT03494933

Aug 10th, 2022 - Heart failure is a leading cause of death, hospitalisation, impaired quality of life and health expenditure. Symptoms and survival can be significantly improved by implantation of a device for Cardiac Resynchronisation Therapy (CRT). CRT devices a...

see more →

Guidelines  9 results

Sudden Death in the Young: Information for the Primary Care Provider.
https://doi.org/10.1542/peds.2021-052044
Pediatrics Erickson CC, Salerno JC et. al.

Jun 23rd, 2021 - There are multiple conditions that can make children prone to having a sudden cardiac arrest (SCA) or sudden cardiac death (SCD). Efforts have been made by multiple organizations to screen children for cardiac conditions, but the emphasis has been...

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Po...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141471
Mayo Clinic Proceedings; Giudicessi JR, Noseworthy PA et. al.

May 4th, 2020 - As the coronavirus disease 19 (COVID-19) global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the "off-label" repurposing of drugs such as hydroxychloroquine and lopinavir/ritonavir, which have the p...

Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Scienc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903778
Circulation Rimm EB, Appel LJ et. al.

May 19th, 2018 - Since the 2002 American Heart Association scientific statement "Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease," evidence from observational and experimental studies and from randomized controlled trials continues to e...

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and ...
https://doi.org/10.1016/j.jacc.2017.10.054
Journal of the American College of Cardiology; Al-Khatib SM, Stevenson WG et. al.

Nov 4th, 2017 - 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and...

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and ...
https://doi.org/10.1161/CIR.0000000000000548
Circulation Al-Khatib SM, Stevenson WG et. al.

Nov 1st, 2017 - 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Prac...

see more →

Drugs  15 results see all →

Clinicaltrials.gov  398 results

Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
https://clinicaltrials.gov/ct2/show/NCT03494933

Aug 10th, 2022 - Heart failure is a leading cause of death, hospitalisation, impaired quality of life and health expenditure. Symptoms and survival can be significantly improved by implantation of a device for Cardiac Resynchronisation Therapy (CRT). CRT devices a...

Ventricular Tachycardia Mechanisms
https://clinicaltrials.gov/ct2/show/NCT05478213

Aug 9th, 2022 - Ventricular tachycardia (VT) ablation remains the cornerstone treatment for drug refractory VT. Previous studies have reported success rate of VT ablation ranging from 23 to 49%. Despite improvements in mapping and catheter technology, there is a ...

Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death
https://clinicaltrials.gov/ct2/show/NCT03248557

Aug 8th, 2022 - Trial design: The AWAKE trial is an investigator-initiated, multicenter, observational trial currently underway in 4 centers in Spain (Hospital Clínico San Carlos, Hospital Universitario La Paz, Hospital General Universitario de Ciudad Real, and H...

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
https://clinicaltrials.gov/ct2/show/NCT04675788

Aug 5th, 2022 - Torsades de pointes (TdP) is a ventricular tachycardia associated with prolongation of the corrected QT (QTc) interval, and which may be caused by > 150 widely used drugs. TdP results in catastrophic outcomes, including sudden cardiac death. Older...

Study of Heart Transplant Rejection
https://clinicaltrials.gov/ct2/show/NCT00042614

Aug 4th, 2022 - Cardiac transplantation has been successful in improving survival in end stage heart failure. But graft rejection has limited survival after transplantation. In the first year, acute cellular rejection and infection remain the most common causes o...

see more →

News  644 results

Exceeding Exercise Guidelines Boosts Survival, to a Point
https://www.medscape.com/viewarticle/977998

Jul 26th, 2022 - A new study suggests that going beyond current guidance on moderate and vigorous physical activity levels may add years to one's life. Americans are advised to do a minimum of 150 to 300 minutes a week of moderate exercise or 75 to 150 minutes a w...

Will You Suffer Cardiac Arrest? New Tech May Predict If and When
https://www.medscape.com/viewarticle/972766

Apr 26th, 2022 - COVID-19 fatalities may have captured more attention lately, but heart disease remains the leading cause of death in the U.S. More than 300,000 Americans this year will die of sudden cardiac arrest (also called sudden cardiac death, or SCD), where...

Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI
https://www.mdedge.com/cardiology/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified-patients
Ted Bosworth

Apr 25th, 2022 - In the placebo-controlled REDUCE-IT trial, icosapent ethyl (IPE) was linked to a significant reduction in major adverse cardiovascular events (MACE) when administered on top of LDL cholesterol control, but a new substudy suggests a greater relativ.

Fast Five Quiz: Hypertrophic Cardiomyopathy
https://www.medscape.com/viewarticle/969363

Apr 13th, 2022 - Hypertrophic cardiomyopathy (HCM) is a genetic disease of the heart characterized by an increase in left ventricular wall thickness (≥ 15 mm) in the absence of abnormal loading conditions (hypertension, congenital heart disease, or valvular diseas...

Fast Five Quiz: Hypertrophic Cardiomyopathy Workup
https://www.medscape.com/viewarticle/969366

Apr 13th, 2022 - Hypertrophic cardiomyopathy (HCM) is a genetic disease of the heart characterized by an increase in left ventricular wall thickness (≥ 15 mm) in the absence of abnormal loading conditions (hypertension, congenital heart disease, or valvular diseas...

see more →

Patient Education  16 results see all →